Product Information

CARBIDOPA-LEVO ER 50-200 TAB is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1735 per EA under NDC 62756045788. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Aug 23, 2007.

CARBIDOPA-LEVO ER 50-200 TAB

CARBIDOPA AND LEVODOPA
$0.1735per EA

Strength

50; 200 mg/1; mg/1

NDC

62756045788

Classification

Generic

Dosage Form

TABLET, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CARBIDOPA; LEVODOPA

Approval Type

Generic (ANDA)

FDA Application

ANDA077828

FDA Approved

8/23/2007

On Market Since

8/23/2007

Pharmacological Classes

Amino Acids
Aromatic
Aromatic Amino Acid

Price Statistics

The NADAC for CARBIDOPA-LEVO ER 50-200 TAB has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 59.1%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1735 per EA
All-time high$0.6666 (May 13, 2015)
All-time low$0.1551 (May 22, 2024)
52-week high$0.2155
52-week low$0.1676
Median price$0.3709
Average price$0.3472
Largest weekly change+52.4% (Jun 19, 2024)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+3.5%

1M

+3.5%

3M

-7.1%

6M

-4.3%

1Y

-19.5%

3Y

-39.8%

5Y

-51.6%

All

-59.1%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CARBIDOPA AND LEVODOPA market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of CARBIDOPA-LEVO ER 50-200 TAB?

The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVO ER 50-200 TAB, manufactured by Sun Pharmaceutical Industries Inc., is $0.1735 per EA (NDC 62756045788), effective Aug 19, 2026.

How has the price of CARBIDOPA-LEVO ER 50-200 TAB changed over time?

Over the history we have for it, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has declined 59.1%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVO ER 50-200 TAB?

Since Nov 28, 2013, the NADAC for CARBIDOPA-LEVO ER 50-200 TAB has ranged from a low of $0.1551 (May 22, 2024) to a high of $0.6666 (May 13, 2015), with a median of $0.3709 per EA.

Are there cheaper alternatives to CARBIDOPA-LEVO ER 50-200 TAB?

No other NADAC-published product currently shares the active ingredient and strength of CARBIDOPA-LEVO ER 50-200 TAB in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CARBIDOPA-LEVO ER 50-200 TAB?

CARBIDOPA-LEVO ER 50-200 TAB (NDC 62756045788) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.